A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells - Xiaolin, Z; Grasso, A W; Kung, H J; Agarwal, R (Cancer Res, 1998)